D-bol 10mg/tab 100 Tabletten by Raw Pharma

Usage

1. Complete pre-cycle bloodwork — serum testosterone, LH, FSH, ALT, and AST — and record baseline values before starting the cycle so PCT endpoint targets are evidence-based rather than estimated.
2. During the final one to two cycle weeks, reduce daily Methandienone intake by one 10 mg tablet every five to seven days; swallow each tablet whole with water and food to maintain consistent GI absorption during the taper.
3. Take the final D-bol tablet on a scheduled day, record the date, and begin a three-to-five day clearance window before SERM initiation — Methandienone's short half-life means the compound has exited systemic circulation by the time SERM therapy opens.
4. Initiate Tamoxifen at 40 mg per day or Clomiphene at 50 mg per day on the first day of PCT; administer the SERM at a consistent time daily to maintain steady LH stimulation as documented in SERM pharmacokinetic literature.
5. Step the SERM dose down in weeks three and four — Tamoxifen to 20 mg, Clomiphene to 25–50 mg — and continue avoiding all 17α-alkylated orals during this window to prevent re-imposing hepatic burden during recovery.
6. At week four of PCT, assess serum testosterone by LC-MS/MS and LH/FSH by immunoassay; results at or approaching the lower limit of the normal reference range confirm axis recovery is progressing and may support a decision to continue or conclude SERM therapy.

Warnings

Frequently asked questions

When should Post Cycle Therapy begin after the last Raw Pharma D-bol tablet?

SERM-based PCT should begin three to five days after the final Methandienone tablet. Because Methandienone carries a short plasma half-life of approximately three to five hours — verified by HPLC-based serum assays — the compound clears systemic circulation within 24 hours, meaning there is no depot ester delay. Starting Tamoxifen or Clomiphene within this window gives the HPG axis an unobstructed stimulus at the earliest practical opportunity.

Which PCT medications are recommended following a Methandienone-only cycle?

Tamoxifen and Clomiphene are the two SERMs supported by androgen-recovery literature for post-Methandienone PCT. A common evidence-referenced protocol runs Tamoxifen at 40 mg per day for the first two weeks, stepping to 20 mg per day for two additional weeks. Clomiphene is sometimes substituted at 50 mg per day for four weeks. Both SERMs stimulate LH and FSH release measured by immunoassay, driving endogenous testosterone recovery after oral androgen suppression.

How long does HPG axis recovery typically take after a short Methandienone oral cycle?

Recovery timelines measured by serum LH return-to-baseline using immunoassay methodology typically span four to ten weeks following a short oral-only Methandienone cycle. This is shorter than recovery documented after equivalent depot-injectable cycles because no ester reservoir extends suppression post-cessation. Serum testosterone measured by LC-MS/MS at the four-week PCT mark provides an objective recovery checkpoint rather than relying on subjective indicators.

Can the Raw Pharma D-bol 10mg tablets be split to achieve a 5mg dose during PCT taper?

Splitting is not recommended. Raw Pharma's per-tablet HPLC content-uniformity testing validates API distribution at the whole-unit level; mechanical splitting introduces variance that the quality-control specification does not cover. For a taper requiring doses below 10 mg, complete cessation and immediate SERM initiation is pharmacologically preferable to imprecise half-tablet approximations.

How does the 100-tablet pack size fit a structured PCT taper protocol?

The 100-tablet count accommodates a variety of taper structures preceding SERM initiation. A practitioner running 20 mg per day through week four, stepping to 10 mg for one final week, consumes 105 tablets total — meaning a single 100-tablet pack covers the taper portion of most four-week cycles with minimal surplus, allowing budget-efficient cycle planning without over-ordering. The blister pack format keeps remaining tablets protected from humidity across the taper window.

Manufacturer

Raw Pharma's oral tablet line — of which D-bol represents the Methandienone expression — is distributed across regional markets through a structured logistics network that prioritises consistent availability in both European and North American pharmacy-adjacent channels. Where some smaller-volume manufacturers accept distribution gaps as a function of limited production capacity, Raw Pharma's scheduling model ties batch-release timing to regional demand forecasts, reducing stockout risk for practitioners mid-cycle or mid-PCT protocol. Each released batch carries a lot-specific Certificate of Analysis recording per-tablet HPLC content-uniformity results and microbial testing outcomes; this documentation travels with the product through the distribution chain rather than being retained internally, giving end-market practitioners access to batch-level quality data without requiring direct manufacturer contact.